{"id":760495,"date":"2025-09-01T14:22:01","date_gmt":"2025-09-01T14:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=760495"},"modified":"2025-09-01T14:22:01","modified_gmt":"2025-09-01T14:22:01","slug":"neuroprosthetics-market-projected-to-reach-usd-1464-billion-by-2032-driven-by-rising-neurological-disorders-and-technological-advancements","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/neuroprosthetics-market-projected-to-reach-usd-1464-billion-by-2032-driven-by-rising-neurological-disorders-and-technological-advancements_760495.html","title":{"rendered":"Neuroprosthetics Market Projected to Reach USD 14.64 Billion by 2032, Driven by Rising Neurological Disorders and Technological Advancements"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/upload\/2025\/09\/1756744106.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Neuroprosthetics Market Projected to Reach USD 14.64 Billion by 2032, Driven by Rising Neurological Disorders and Technological Advancements\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/09\/1756744106.jpg\" alt=\"Neuroprosthetics Market Projected to Reach USD 14.64 Billion by 2032, Driven by Rising Neurological Disorders and Technological Advancements\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Neuroprosthetics Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Neuroprosthetics companies shaping the industry include: Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., Demant A\/S, Synapse Biomedical Inc., Cognixion, Inc., and others.<\/div>\n<p style=\"text-align: justify;\"><em>Albany, United States, September 2025<\/em> &ndash; The global <strong>Neuroprosthetics Market<\/strong> is poised for strong growth, with market size projected to more than double from <strong>USD 7.14 billion in 2024 to USD 14.64 billion by 2032<\/strong>, advancing at a <strong>CAGR of 12.75%<\/strong> during the forecast period (2025&ndash;2032). The market is witnessing robust demand fueled by the increasing prevalence of neurological disorders, rising incidence of nerve injuries, hearing and vision impairments, and accelerating research and development (R&amp;D) efforts by key industry players.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Recent Developments in the Neuroprosthetics Market<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Feb 2024<\/strong> &ndash; <em>Boston Scientific Corporation<\/em> received FDA approval for its <strong>WaveWriter&trade; SCS Systems<\/strong> for chronic low back and leg pain.<\/li>\n<li><strong>Jan 2024<\/strong> &ndash; <em>Abbott Laboratories<\/em> secured FDA approval for <strong>Liberta RC&trade;, the world&rsquo;s smallest rechargeable DBS system<\/strong>, treating Parkinson&rsquo;s disease and essential tremor.<\/li>\n<li><strong>Apr 2024<\/strong> &ndash; <em>Medtronic<\/em> received FDA approval for <strong>Inceptiv&trade;, a closed-loop rechargeable spinal cord stimulator<\/strong> for chronic pain.<\/li>\n<li><strong>Mar 2021<\/strong> &ndash; <em>Second Sight Medical Products<\/em> gained FDA approval for <strong>Argus 2s Retinal Prosthesis System<\/strong>, enabling vision restoration for the blind.<\/li>\n<li><strong>Jan 2021<\/strong> &ndash; <em>Boston Scientific<\/em> launched its <strong>Vercise Genus DBS System<\/strong> for advanced Parkinson&rsquo;s disease management.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover how groundbreaking FDA approvals and next-generation technologies are shaping the future of neuroprosthetics. Stay ahead with in-depth insights into market growth, key innovations, and leading players driving advancements in neurological care. @ Download the Full <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/neuroprosthetics-market-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Neuroprosthetics Market Report<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Growing Need for Neuroprosthetics<\/strong><\/p>\n<p style=\"text-align: justify;\">Neuroprosthetics are implantable devices designed to restore or replace lost neurological functions by directly interacting with the nervous system. These devices are playing a critical role in improving the quality of life for individuals suffering from conditions such as <strong>spinal cord injuries, motor neuron disorders, Alzheimer&rsquo;s disease, Parkinson&rsquo;s disease, and sensory impairments including hearing and vision loss<\/strong>.<\/p>\n<p style=\"text-align: justify;\">According to the <strong>World Health Organization (WHO)<\/strong>, approximately <strong>15.4 million people were living with spinal cord injuries worldwide in 2021<\/strong>. Similarly, the <strong>United Spinal Association<\/strong> highlighted that around <strong>17,700 new spinal cord injury cases are diagnosed annually in the United States<\/strong>. Neuroprosthetic solutions such as <strong>motor prosthetics and spinal cord stimulators<\/strong> have become essential in restoring mobility and function in such patients, underscoring their growing importance in healthcare.<\/p>\n<p style=\"text-align: justify;\">Furthermore, the burden of neurodegenerative and cognitive disorders continues to rise globally. WHO data from 2023 revealed that <strong>55 million people worldwide are currently living with dementia<\/strong>, with nearly <strong>10 million new cases reported each year<\/strong>. Alzheimer&rsquo;s disease accounts for 60&ndash;70% of these cases. As the incidence of neurological disorders increases, the demand for neuroprosthetic devices is expected to expand significantly.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Unlock the full report to benchmark competitor activities, track recent product approvals, and identify investment opportunities in the evolving Neuroprosthetics market @ <em><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/neuroprosthetics-market-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Neuroprosthetics Market Size and Forecast<\/a><\/em><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Expanding Role in Sensory Impairments<\/strong><\/p>\n<p style=\"text-align: justify;\">Beyond motor and cognitive applications, neuroprosthetics are addressing the rising prevalence of sensory impairments. WHO reported in 2023 that over <strong>190 million Europeans suffer from hearing loss<\/strong>, a number projected to surpass <strong>230 million by 2050<\/strong>. <strong>Cochlear implants<\/strong>, a leading type of auditory neuroprosthetic, are transforming the lives of individuals with severe hearing impairments by bypassing damaged parts of the ear and directly stimulating the auditory nerve. Similarly, <strong>retinal prosthetics<\/strong> are advancing to help restore vision for patients with degenerative eye conditions.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Neuroprosthetics Market Drivers<\/strong><\/p>\n<p style=\"text-align: justify;\">The market growth is being driven by:<\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Rising incidence of neurological disorders and injuries<\/strong> such as ALS, Parkinson&rsquo;s, dementia, spinal muscular atrophy, and CRPS.<\/li>\n<li><strong>Increasing adoption of neuroprosthetic devices<\/strong> for hearing loss and vision impairment.<\/li>\n<li><strong>Technological advancements and product approvals<\/strong>, including next-generation closed-loop systems and brain-computer interface (BCI) solutions.<\/li>\n<li><strong>Expanding R&amp;D collaborations<\/strong> such as Rice University and Houston Methodist&rsquo;s Center for Translational Neural Prosthetics.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">However, challenges such as <strong>high costs, limited accessibility in low-income regions, and shortage of specialized training<\/strong> continue to restrain widespread adoption. Overcoming these barriers remains crucial for unlocking the full potential of neuroprosthetic technologies.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Access in-depth insights, including growth forecasts, pipeline developments, and competitive landscapes, to guide your investment and strategic planning @ <em><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/neuroprosthetics-market-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Neuroprosthetics Market Drivers and Barriers<\/a><\/em><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Market Segmentation Insights<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Market Segmentation By Type<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Motor Prosthetics<\/li>\n<li>Cognitive Prosthetics<\/li>\n<li>Auditory Prosthetics (Cochlear Implants)<\/li>\n<li>Visual Prosthetics (Retinal Implants)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Market Segmentation By Procedure<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Invasive<\/li>\n<li>Non-Invasive<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Market Segmentation By Technology<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Deep Brain Stimulation (DBS)<\/li>\n<li>Vagus Nerve Stimulation (VNS)<\/li>\n<li>Sacral Nerve Stimulation (SNS)<\/li>\n<li>Spinal Cord Stimulation (SCS)<\/li>\n<li>Transcranial Magnetic Stimulation (TMS)<\/li>\n<li>Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Market Segmentation By End-User<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Hospitals<\/li>\n<li>Ambulatory Surgical Centers<\/li>\n<li>Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Market Segmentation By Geography<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>North America Neuroprosthetics Market<\/li>\n<li>Europe Neuroprosthetics Market<\/li>\n<li>Asia-Pacific Neuroprosthetics Market<\/li>\n<li>Rest of the World<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Among these, the <strong>Spinal Cord Stimulation (SCS) segment<\/strong> is anticipated to hold a leading share due to its effectiveness in treating chronic pain, failed back syndrome, and CRPS. According to the National Organization for Rare Disorders, approximately <strong>200,000 people in the U.S. are affected by CRPS annually<\/strong>, further boosting SCS adoption.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Gain exclusive access to detailed segmentation, competitive benchmarking, and emerging opportunities in the Neuroprosthetics Market &ndash; Forecast 2032. @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/neuroprosthetics-market-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Neuroprosthetics Market Insight and Competitive Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Regional Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>North America: Neuroprosthetics Market Leader<\/strong><\/p>\n<p style=\"text-align: justify;\">North America is expected to dominate the neuroprosthetics market during the forecast period, driven by:<\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>High prevalence of Alzheimer&rsquo;s, Parkinson&rsquo;s, and depression<\/strong>.<\/li>\n<li><strong>Increasing hearing loss cases<\/strong> &ndash; CDC reported <strong>6,520 cases of permanent hearing loss in 2021 in the U.S.<\/strong><\/li>\n<li><strong>Rapid technological innovation<\/strong> &ndash; U.S.-based Blackrock Neurotech introduced <strong>Neuralace&trade;<\/strong>, a next-gen neural interface enabling memory restoration and mental health disorder treatment.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Europe &amp; Asia-Pacific: Emerging Growth Hubs<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Europe<\/strong> Neuroprosthetics Market benefits from a growing elderly population, high prevalence of dementia, and advanced healthcare systems.<\/li>\n<li><strong>Asia-Pacific<\/strong> Neuroprosthetics Market offers vast growth potential due to improving healthcare infrastructure, rising disposable incomes, and a disproportionately high burden of hearing loss in low- and middle-income countries.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Players in the Neuroprosthetics Market<\/strong><\/p>\n<p style=\"text-align: justify;\">Prominent Neuroprosthetics companies shaping the industry include: <strong>Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., Demant A\/S, Synapse Biomedical Inc., Cognixion, Inc.,<\/strong> and others.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Schedule a Personalized Market Strategy Call. Connect with our analysts to discuss how evolving trends in embolic protection technologies can impact your business and identify high-growth opportunities across regions @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/neuroprosthetics-market-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Neuroprosthetics Companies and Manufacturers<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Neuroprosthetics Future Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">The neuroprosthetics industry is set for transformative growth as innovation accelerates. Market expansion will be driven by:<\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Next-gen brain-computer interfaces (BCIs)<\/strong> enabling direct communication between the brain and external devices.<\/li>\n<li><strong>Miniaturization and wireless neuroprosthetics<\/strong>, enhancing patient comfort and reducing complications.<\/li>\n<li><strong>Wider adoption in developing economies<\/strong> as healthcare infrastructure improves.<\/li>\n<li><strong>Strategic collaborations and investments<\/strong> between research institutions, start-ups, and leading corporations.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Despite challenges around affordability and accessibility, the increasing global burden of neurological conditions ensures a promising outlook for neuroprosthetic technologies.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Neuroprosthetics Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Neuroprosthetics Market Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. Neuroprosthetics Competitive Landscape<\/p>\n<p style=\"text-align: justify;\">4. Neuroprosthetics Regulatory Analysis<\/p>\n<p style=\"text-align: justify;\">5. Neuroprosthetics Market Key Factors Analysis<\/p>\n<p style=\"text-align: justify;\">6. Neuroprosthetics Market Porter&rsquo;s Five Forces Analysis<\/p>\n<p style=\"text-align: justify;\">7. Neuroprosthetics Market Assessment<\/p>\n<p style=\"text-align: justify;\">8. Neuroprosthetics Market Company and Product Profiles<\/p>\n<p style=\"text-align: justify;\">8.1. Medtronic<\/p>\n<p style=\"text-align: justify;\">8.2. Boston Scientific Corporation<\/p>\n<p style=\"text-align: justify;\">8.3. Abbott Laboratories<\/p>\n<p style=\"text-align: justify;\">8.4. NeuroPace, Inc.<\/p>\n<p style=\"text-align: justify;\">8.5. Cochlear Ltd.<\/p>\n<p style=\"text-align: justify;\">8.6. Sonova<\/p>\n<p style=\"text-align: justify;\">8.7. NeuroSigma, Inc.<\/p>\n<p style=\"text-align: justify;\">8.8. Blackrock Neurotech<\/p>\n<p style=\"text-align: justify;\">8.9. Synchron<\/p>\n<p style=\"text-align: justify;\">8.10. LivaNova, Inc.<\/p>\n<p style=\"text-align: justify;\">8.11. MED-EL Medical Electronics<\/p>\n<p style=\"text-align: justify;\">8.12. BrainGate<\/p>\n<p style=\"text-align: justify;\">8.13. NEVRO CORP.<\/p>\n<p style=\"text-align: justify;\">8.14. Terumo Corporation<\/p>\n<p style=\"text-align: justify;\">8.15. Penumbra, Inc.<\/p>\n<p style=\"text-align: justify;\">8.16. BrainCo, Inc.<\/p>\n<p style=\"text-align: justify;\">8.17. Axoft Inc.<\/p>\n<p style=\"text-align: justify;\">8.18. Demant A\/S<\/p>\n<p style=\"text-align: justify;\">8.19. Synapse Biomedical Inc.<\/p>\n<p style=\"text-align: justify;\">8.20. Cognixion, Inc.<\/p>\n<p style=\"text-align: justify;\">9. Neuroprosthetics KOL Views<\/p>\n<p style=\"text-align: justify;\">10. Project Approach<\/p>\n<p style=\"text-align: justify;\">11. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">12. Disclaimer &amp; Contact Us<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a <strong>leading market research and consulting firm<\/strong> specializing in life sciences. With expertise spanning <strong>drug development, market analysis, and healthcare consulting<\/strong>, DelveInsight supports pharmaceutical and biotech companies in navigating complex challenges, identifying growth opportunities, and accelerating innovation in oncology and beyond.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=neuroprosthetics-market-projected-to-reach-usd-1464-billion-by-2032-driven-by-rising-neurological-disorders-and-technological-advancements\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +14699457679<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/primary-research-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/primary-research-services<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=neuroprosthetics-market-projected-to-reach-usd-1464-billion-by-2032-driven-by-rising-neurological-disorders-and-technological-advancements\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuroprosthetics Market Neuroprosthetics companies shaping the industry include: Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/neuroprosthetics-market-projected-to-reach-usd-1464-billion-by-2032-driven-by-rising-neurological-disorders-and-technological-advancements_760495.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-760495","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/760495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=760495"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/760495\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=760495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=760495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=760495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}